The “toll” of opioid-induced glial activation: improving the clinical efficacy of opioids by targeting glia

Cited by (438)

Items 201–300 of 438

1. PPARγ activation by pioglitazone does not suppress cravings for alcohol, and is associated with a risk of myopathy in treatment seeking alcohol dependent patients: a randomized controlled proof of principle study
   Melanie L. Schwandt, Nancy Diazgranados, John C. Umhau, Laura E. Kwako, David Ted George, Markus A Heilig · 2020 · Psychopharmacology
2. Enhancement of meditation analgesia by opioid antagonist in experienced meditators
   May, Lisa M., Kosek, Peter, Zeidan, Fadel, Berkman, Elliot T. · 2018 · Psychosomatic Medicine
3. Chapter 23. Cognitive-Behavioral Therapy
   Kathleen M. Carroll, Brian D. Kiluk · 2021 · American Psychiatric Association Publishing eBooks
4. Chapter 27. Family Therapy
   Peter Steinglass · 2021 · American Psychiatric Association Publishing eBooks
5. Chapter 25. Motivational Enhancement
   Matisyahu Shulman, Katherine Pruzan, Kenneth M. Carpenter · 2021 · American Psychiatric Association Publishing eBooks
6. Chapter 44. Mood Disorders
   Jonathan M. Wai, Matisyahu Shulman, Edward V. Nunes · 2021 · American Psychiatric Association Publishing eBooks
7. Pronociceptive and Antinociceptive Effects of Buprenorphine in the Spinal Cord Dorsal Horn Cover a Dose Range of Four Orders of Magnitude
   K. J. Gerhold, Ruth Drdla-Schutting, Silke D. Honsek, Liesbeth Forsthuber, Jürgen Sandkühler · 2015 · Journal of Neuroscience
8. Withdrawal-associated injury site pain (WISP): a descriptive case series of an opioid cessation phenomenon
   Launette Marie Rieb, Wendy V. Norman, Ruth Elwood Martin, Jonathan Berkowitz, Evan Wood, Ryan McNeil, M‐J Milloy · 2016 · Pain
9. Involvement of delta opioid receptors in alcohol withdrawal-induced mechanical allodynia in male C57BL/6 mice
   Doungkamol Alongkronrusmee, Terrance Chiang, Richard M. van Rijn · 2016 · Drug and Alcohol Dependence
10. Stereochemistry and innate immune recognition: (+)‐norbinaltorphimine targets myeloid differentiation protein 2 and inhibits toll‐like receptor 4 signaling
    Xiaozheng Zhang, Yinghua Peng, Peter M. Grace, Matthew D. Metcalf, Andrew J. Kwilasz, Yibo Wang, Tianshu Zhang, Siru Wu, Brandon R. Selfridge, Philip S. Portoghese et al. · 2019 · The FASEB Journal
11. Alpha-asarone alleviates cutaneous hyperalgesia by inhibiting hyperexcitability and neurogenic inflammation via TLR4/NF-κB/NLRP3 signaling pathway in a female chronic migraine rat model
    Qi Liu, Ruijie Yan, Ling Wang, Rui Li, Di Zhang, Can Liao, Shengjun Mao · 2024 · Neuropharmacology
12. Acute Morphine Exposure Increases the Brain Distribution of [18F]DPA-714, a PET Biomarker of Glial Activation in Nonhuman Primates
    Sylvain Auvity, Wadad Saba, Sébastien Goutal, Claire Leroy, Irène Buvat, Jérôme Cayla, Fabien Caillé, Michel Bottlaender, Salvatore Cisternino, Nicolas Tournier · 2016 · The International Journal of Neuropsychopharmacology
13. The bivalent ligand MCC22 potently attenuates hyperalgesia in a mouse model of cisplatin-evoked neuropathic pain without tolerance or reward
    Giuseppe Cataldo, Samuel J. Erb, Mary M. Lunzer, Nhungoc Luong, Eyup Akgün, Philip S. Portoghese, Julie K. Olson, Donald A. Simone · 2019 · Neuropharmacology
14. The Relationship Between Opioids and Immune Signalling in the Spinal Cord
    Jacob Thomas, Sanam Mustafa, Jacinta Lee Johnson, Lauren L. Nicotra, Mark Rowland Hutchinson · 2015 · Handbook of experimental pharmacology
15. Molecular and cellular basis of mu-opioid receptor signaling: mechanisms underlying tolerance and dependence development
    Michael Swingler, Martina Donadoni, Ellen M. Unterwald, Sanjay B. Maggirwar, Ilker Kudret Sariyer · 2025 · Frontiers in Neuroscience
16. Extracellular vesicle-mediated delivery of anti-miR-106b inhibits morphine-induced primary ciliogenesis in the brain
    Rong Ma, Naseer A. Kutchy, Zhongbin Wang, Guoku Hu · 2023 · Molecular Therapy
17. Trimethoxyflavanone relieves Paclitaxel-induced neuropathic pain via inhibiting expression and activation of P2X7 and production of CGRP in mice
    Changqing Mei, Pan Chen, Linbin Xu, Mengmeng Miao, Qichen Lu, Yang Yu, Pengyu Lin, Wenwei Wu, Feng Ni, Yinping Gao et al. · 2023 · Neuropharmacology
18. The Use of the Coenzyme Q10 as a Food Supplement in the Management of Fibromyalgia: A Critical Review
    Luca Campisi, Concettina La Motta · 2022 · Antioxidants
19. State of the science review
    John L. Clifford, Marcie Fowler, Jacob J. Hansen, Bopaiah P. Cheppudira, Jennifer E. Nyland, Margaux M. Salas, Laura L. McGhee, Lawrence N. Petz, Dayna Loyd Averitt · 2014 · The Journal of Trauma: Injury, Infection, and Critical Care
20. Chronic Daily Headache: Mechanisms and Principles of Management
    Amy W. Voigt, Harry J. Gould · 2016 · Current Pain and Headache Reports
21. Management of Patients With Orofacial Pain and Temporomandibular Disorders
    Gary F. Bouloux, Joli C. Chou, Vincent E. DiFabio, Gregory M. Ness, Daniel Pérez, Louis Gerard Mercuri, William L. Chung, Gary D. Klasser, Steven D. Bender, Steven L. Kraus et al. · 2024 · Journal of Oral and Maxillofacial Surgery
22. Clinical Neuroscience of Addiction: Similarities and Differences Between Alcohol and Other Drugs
    Hollis C. Karoly, Sophie L. YorkWilliams, Kent E. Hutchison · 2015 · Alcoholism Clinical and Experimental Research
23. CXCL12/CXCR4 Signaling Contributes to the Pathogenesis of Opioid Tolerance: A Translational Study
    Chih‐Peng Lin, Kai‐Hsiang Kang, Huang‐Ju Tu, Ming‐Yueh Wu, Tzu‐Hung Lin, Houng‐Chi Liou, Wei‐Zen Sun, Wen Fu · 2016 · Anesthesia & Analgesia
24. Assessment of pioglitazone and proinflammatory cytokines during buprenorphine taper in patients with opioid use disorder
    Jennifer R. Schroeder, Karran A. Phillips, David H. Epstein, Michelle L. Jobes, Melody A. Furnari, Ashley Kennedy, Markus A Heilig, Kenzie L. Preston · 2018 · Psychopharmacology
25. Opioid Adjuvant Strategy: Improving Opioid Effectiveness
    Frederic J.‐J. Bihel · 2016 · Future Medicinal Chemistry
26. Glial cells modulate hippocampal synaptic plasticity in morphine dependent rats
    آزاده الهی ماهانی, Soomaayeh Heysieattalab, Narges Hosseinmardi, Mahyar Janahmadi, Fatemehsadat Seyedaghamiri, Habibeh Khoshbouei · 2018 · Brain Research Bulletin
27. Cannabinoids, Pain, and Opioid Use Reduction: The Importance of Distilling and Disseminating Existing Data
    Hutchison, Kent E., Hagerty, Sarah L., Galinkin, Jeffrey, Bryan, Angela D., Bidwell, L. Cinnamon · 2019 · Cannabis & Cannabinoid Research
28. Cathepsin S in the spinal microglia contributes to remifentanil-induced hyperalgesia in rats
    L. Ye, Li Xiao, SY. Yang, JJ. Duan, Y. Chen, Yu Cui, Yuhan Chen · 2016 · Neuroscience
29. Potential role of CXCL10/CXCR3 signaling in the development of morphine tolerance in periaqueductal gray
    Wei Wang, Yawen Peng, Hui Yang, Huilian Bu, Genhua Guo, Dai-Qiang Liu, Bin Shu, Xuebi Tian, Ailin Luo, Xuming Zhang et al. · 2017 · Neuropeptides
30. Microglial alterations induced by psychoactive drugs: A possible mechanism in substance use disorder?
    Clarissa Catale, Silvia Bussone, Luisa Lo Iacono, Valeria Carola · 2019 · Seminars in Cell and Developmental Biology
31. Glial dysfunction and persistent neuropathic postsurgical pain
    Linda Block · 2015 · Scandinavian Journal of Pain
32. Central amygdala inflammation drives pain hypersensitivity and attenuates morphine analgesia in experimental autoimmune encephalomyelitis
    Zoë Dworsky-Fried, Christian A. Faig, Holly A. Vogel, Bradley J. Kerr, Anna M.W. Taylor · 2021 · Pain
33. Multiple Sclerosis and the Endogenous Opioid System
    Zoë Dworsky-Fried, Caylin I. Chadwick, Bradley J. Kerr, Anna M.W. Taylor · 2021 · Frontiers in Neuroscience
34. The opioid antagonist, β-funaltrexamine, inhibits NF-κB signaling and chemokine expression in human astrocytes and in mice
    Randall L. Davis, Subhas Das, J. Thomas Curtis, Craig W. Stevens · 2015 · European Journal of Pharmacology
35. Neuropsychological and neuroanatomical sequelae of chronic non-malignant pain and opioid analgesia
    C. Block, L. Cianfrini · 2013 · NeuroRehabilitation (Reading, MA)
36. Toll-Like Receptors and Itch
    Tong Liu, Ru‐Rong Ji · 2014 · CRC Press eBooks
37. Opioid antagonists for pain
    Robert Taylor, Joseph V. Pergolizzi, Frank Porreca, Robert B. Raffa · 2013 · Expert Opinion on Investigational Drugs
38. The use of opioids for treatment of cancer pain
    Sebastiano Mercadante · 2014 · Expert Opinion on Pharmacotherapy
39. Chronic immune stimulation as a contributing cause of chronic disease in opiate addiction including multi-system ageing
    Albert Stuart Reece · 2010 · Medical Hypotheses
40. Intraoperative electroacupuncture relieves remifentanil-induced postoperative hyperalgesia via inhibiting spinal glial activation in rats
    Chang-xi Shi, Yue Liu, Wei Zhang, Yishan Lei, Cui’e Lu, Rao Sun, Yue Sun, Ming Jiang, Xiaoping Gu, Zhengliang Ma · 2017 · Molecular Pain
41. Physiopathology of fibromyalgia
    Diego Felipe García Rodríguez, Carlos Abud‐Mendoza · 2020 · Reumatología Clínica (English Edition)
42. Sex differences in morphine sensitivity are associated with differential glial expression in the brainstem of rats with neuropathic pain
    Damien C. Boorman, Kevin A. Keay · 2022 · Journal of Neuroscience Research
43. Mechanisms of Remifentanil-Induced Postoperative Hyperalgesia: A Comprehensive Review
    Kexin Zhu, Xiaolin Wen, Xuan Mei, Fang Fang, Tianyao Zhang · 2025 · Drug Design Development and Therapy
44. Repeated Use of Morphine Induces Anxiety by Affecting a Proinflammatory Cytokine Signaling Pathway in the Prefrontal Cortex in Rats
    Shamseddin Ahmadi, Shiva Mohammadi Talvar, Kayvan Masoudi, Mohammad Zobeiri · 2022 · Molecular Neurobiology
45. Pathophysiology of pain
    Stephan Alexander Schug, Helen C.S. Daly, Kathryn J.D. Stannard · 2011 · University of Adelaide Press eBooks
46. Reactive microglia after taste nerve injury: comparison to nerve injury models of chronic pain
    Dianna L Bartel, Thomas E. Finger · 2013 · F1000Research
47. The effect of substance P1–7 amide on nociceptive threshold in diabetic mice
    Masahiro Ohsawa, Anna Carlsson, Megumi Asato, Takayuki Koizumi, Yuki Nakanishi, Rebecca Fransson, Anja Sandström, Mathias Hallberg, Fred Nyberg, Junzo Kamei · 2010 · Peptides
48. Inhibition of morphine tolerance is mediated by painful stimuli via central mechanisms
    Shigeki Iwai · 2012 · Drug Discoveries & Therapeutics
49. Evaluation of TSPO PET imaging, a marker of glial activation, to study the neuroimmune footprints of morphine exposure and withdrawal
    Sylvain Auvity, Sébastien Goutal, Benoît Thezé, Catarina Chaves, Benoît Hosten, Bertrand Kühnast, Wadad Saba, Raphaël Boisgard, Irène Buvat, Salvatore Cisternino et al. · 2016 · Drug and Alcohol Dependence
50. Attitudes Towards and Management of Opioid-induced Hyperalgesia
    Elena Kum, Norman Buckley, Oscar A. de León-Casasola, Mark J. Lema, Jason Walter Busse · 2020 · Clinical Journal of Pain
51. Pathophysiological Mechanisms of Neuropathic Pain
    Caterina Maria Leone, Antonella Biasiotta, Silvia La Cesa, Giulia Di Stefano, G. Cruccu, Andrea Truini · 2011 · Future Neurology
52. Glial TLR4 signaling does not contribute to opioid-induced depression of respiration
    Jennifer D. Zwicker, Yong Zhang, Jun Tao Ren, Mark Rowland Hutchinson, Kenner C. Rice, Linda R. Watkins, John J. Greer, Gregory Douglas Funk · 2014 · Journal of Applied Physiology
53. Ginger Extract Reduces Chronic Morphine-Induced Neuroinflammation and Glial Activation in Nucleus Accumbens of Rats.
    Shima Torkzadeh-Mahani, Saeed Esmaeili‐Mahani, Sima Nasri, Fatemeh Darvishzadeh Mahani, Reyhaneh Naderi · 2019 · Europe PMC (PubMed Central)
54. Pharmacologic agents directed at the treatment of pain associated with maladaptive neuronal plasticity
    Joseph V. Pergolizzi, Giustino Varrassi, Peter Magnusson, Frank Breve, Robert B. Raffa, Paul J. Christo, Maninder Chopra, Antonella Paladini, Jo Ann LeQuang, Kailyn Mitchell et al. · 2021 · Expert Opinion on Pharmacotherapy
55. Interleukin-1 receptor-associated kinase 4 (IRAK4) in the nucleus accumbens regulates opioid-seeking behavior in male rats
    Ruyan Wu, Jianfeng Liu, Jimmy Vu, Yufei Huang, David Dietz, Jun‐Xu Li · 2021 · Brain Behavior and Immunity
56. Exploring neuroinflammation as a potential avenue to improve the clinical efficacy of opioids
    Jacob Thomas, Mark Rowland Hutchinson · 2012 · Expert Review of Neurotherapeutics
57. Medical management of acute pain in patients with chronic pain
    Mario De Pinto, Alex Cahana · 2012 · Expert Review of Neurotherapeutics
58. Morphine-3-glucuronide causes antinociceptive cross-tolerance to morphine and increases spinal substance P expression
    Kim Juhani Blomqvist, Hanna Viisanen, Fredrik H.G. Ahlström, Viljami Jokinen, Yulia A. Sidorova, Ilida Suleymanova, Pekka Veli Rauhala, Eija Anneli Kalso, Tuomas Olavi Lilius · 2020 · European Journal of Pharmacology
59. Changes in the NMR Metabolic Profile of Human Microglial Cells Exposed to Lipopolysaccharide or Morphine
    Issam El Ghazi, Wen S. Sheng, Shuxian Hu, Brian G. Reilly, James R. Lokensgard, Robert Bryan Rock, Phillip K. Peterson, George L. Wilcox, Ian M. Armitage · 2010 · Journal of Neuroimmune Pharmacology
60. The endocannabinoid system and breathing
    Beth M. Wiese, Angelica Alvarez Reyes, Todd W. Vanderah, Tally M. Largent‐Milnes · 2023 · Frontiers in Neuroscience
61. Neuropeptide and cytokine regulation of pain in the context of substance use disorders
    Elizabeth Delery, Scott Edwards · 2020 · Neuropharmacology
62. Viral vector-mediated gene therapy for opioid use disorders
    Tao Wang, Xun Zhu, Hyun Yi, Jun Gu, Shue Liu, Sari Izenwasser, Vance Lemmon, Sabita Roy, Shuanglin Hao · 2021 · Experimental Neurology
63. Dexmedetomidine attenuates haemorrhage-induced thalamic pain by inhibiting the TLR4/NF-κB/ERK1/2 pathway in mice
    Tianfeng Huang, Yong Hui Li, Wenqing Hu, Dapeng Yu, Ju Gao, Fan Yang, Yingying Xu, Zehua Wang, Liang Zong · 2021 · Inflammopharmacology
64. The Ameliorative Effects of Isorhynchophylline on Morphine Dependence Are Mediated Through the Microbiota-Gut-Brain Axis
    Zhu Chen, Chen Zhijie, Zhou Yuting, Chan Li, Xiao Shilin, Zhou Qichun, Jinying Ou, Jing Li, Luo Chaohua, MO Zhi-xian · 2021 · Frontiers in Pharmacology
65. Immunomodulatory Role of Complement Proteins in the Neuropathology Associated with Opiate Abuse and HIV-1 Co-Morbidity
    Supriya D. Mahajan, Ravikumar Aalinkeel, Neil U. Parikh, Alexander Jacob, Katherine Cwiklinski, Prateet Sandhu, Kevin X. Le, Alexander W. Loftus, Stanley A. Schwartz, Richard John Quigg et al. · 2017 · Immunological Investigations
66. Lipid raft disruption as an opportunity for peripheral analgesia
    Andrea Kinga Nehr-Majoros, Ágnes Király, Zsuzsanna Helyes, Éva Szőke · 2024 · Current Opinion in Pharmacology
67. Potentiation of acute morphine‐induced analgesia measured by a thermal test in bone cancer‐bearing mice
    Sara González‐Rodríguez, Sara Gómez Llames, Agustı́n Hidalgo, Ana Baamonde, Luis Menéndez · 2011 · Fundamental and Clinical Pharmacology
68. The “Culture” of Pain Control: A Review of Opioid-Induced Dysbiosis (OID) in Antinociceptive Tolerance
    Ryan A. Mischel, Karan H. Muchhala, William L. Dewey, Hamid I. Akbarali · 2019 · Journal of Pain
69. Relative and Age-dependent Stimulation of Soluble and Cellular Immunity in Opiate Dependence
    Albert Stuart Reece · 2011 · Journal of Addiction Medicine
70. Bivalent ligand MCC22 potently attenuates nociception in a murine model of sickle cell disease
    Giuseppe Cataldo, Mary M. Lunzer, Julie K. Olson, Eyup Akgün, John D. Belcher, Gregory M. Vercellotti, Philip S. Portoghese, Donald A. Simone · 2018 · Pain
71. Identification of Novel Analgesics Through a Drug Repurposing Strategy
    Parisa Gazerani · 2019 · Pain Management
72. The ambiguity of opioids revealed by immunology is changing the knowledge and the therapeutic approach in cancer and non-cancer pain: A narrative review
    Angela Santoni, Edoardo Arcuri · 2020 · Immunology Letters
73. Regulation of Pleiotrophin, Midkine, Receptor Protein Tyrosine Phosphatase β/ζ, and Their Intracellular Signaling Cascades in the Nucleus Accumbens During Opiate Administration
    Daniel García‐Pérez, Maria Luisa Laorden, M. Victoria Milanés · 2015 · The International Journal of Neuropsychopharmacology
74. Endomorphin analog exhibited superiority in alleviating neuropathic hyperalgesia via weak activation of NMDA receptors
    Mengtao Ma, Zhaojuan Wang, Jing Wang, Shuang Wei, Jiaming Cui, Yuan Wang, Keyao Luo, Long Zhao, Xin Liu, Rui Wang · 2020 · Journal of Neurochemistry
75. The Condition of Neuropathic Pain
    Cory C. Toth, Dwight E. Moulin · 2013 · Cambridge University Press eBooks
76. Morphine Attenuates Apically-Directed Cytokine Secretion from Intestinal Epithelial Cells in Response to Enteric Pathogens
    Amanda J. Brosnahan, Bryan J. Jones, Cheryl M.T. Dvorak, David R. Brown · 2014 · Pathogens
77. Central IRAK-4 kinase inhibition for the treatment of pain following nerve injury in rats
    Katrien Pletinckx, Duygu Krings, André Welbers, David A. Rider, Torsten R. Dunkern · 2020 · Brain Behavior and Immunity
78. Sphingosine-1-phosphate receptor subtype 1 activation in the central nervous system contributes to morphine withdrawal in rodents
    Timothy M. Doyle, Mark Rowland Hutchinson, Kathryn Braden, Kali Janes, Vicky Staikopoulos, Zhoumou Chen, William L. Neumann, Sarah Spiegel, Daniela Salvemini · 2020 · Journal of Neuroinflammation
79. Current and Evolving Concepts in the Management of Complex Regional Pain Syndrome: A Narrative Review
    Burcu Candan, Semih Güngör · 2025 · Diagnostics
80. Leukemia inhibitory factor (LIF) potentiates antinociception activity and inhibits tolerance induction of opioids
    Houan Tu, Kai‐Hsiang Kang, Shih‐Yin Ho, H.C. Liou, Horng‐Huei Liou, C.P. Lin, Wen Fu · 2016 · British Journal of Anaesthesia
81. [Toll-like receptor 4: the potential therapeutic target for neuropathic pain].
    Zejun Jia, Feixiang Wu, Qinghai Huang, Jianmin Liu · 2012 · PubMed
82. Hippocampal glial cells modulate morphine-induced behavioral responses
    Fatemehsadat Seyedaghamiri, Soomaayeh Heysieattalab, Narges Hosseinmardi, Mahyar Janahmadi, آزاده الهی ماهانی, Farhad Salari, Mehdi Golpayegani, Habibeh Khoshbouei · 2018 · Physiology & Behavior
83. Contribution of TSPO imaging in the understanding of the state of gliosis in substance use disorders
    Claire Leroy, Wadad Saba · 2021 · European Journal of Nuclear Medicine and Molecular Imaging
84. Receptor Transporter Protein 4 (RTP4) in the Hypothalamus Is Involved in the Development of Antinociceptive Tolerance to Morphine
    Wakako Fujita, Hitoshi Uchida, Masashi Kawanishi, Yusuke Kuroiwa, Manabu Abe, Kenji Sakimura · 2022 · Biomolecules
85. Conventional cancer treatment alone or with regional hyperthermia for pain relief in lung cancer: A case–control study
    Yeon‐Pyo Kim, Yuri Choi, Sun Kim, Yoon-Sung Park, In‐Jae Oh, Kyu‐Sik Kim, Young‐Chul Kim · 2015 · Complementary Therapies in Medicine
86. The Melatonin Type 2 Receptor Agonist IIK7 Attenuates and Reverses Morphine Tolerance in Neuropathic Pain Rats Through the Suppression of Neuroinflammation in the Spinal Cord
    Yaswanth Kuthati, Chih‐Shung Wong · 2024 · Pharmaceuticals
87. Nalmefene non-enantioselectively targets myeloid differentiation protein 2 and inhibits toll-like receptor 4 signaling: wet-lab techniques and in silico simulations
    Xiaozheng Zhang, Hongshuang Wang, Yibo Wang, Hongyuan Li, Siru Wu, Jingwei Gao, Tianshu Zhang, Jun Xie, Xiaohui Wang · 2021 · Physical Chemistry Chemical Physics
88. Glial modulators as novel therapeutics for comorbid pain and opioid use disorder
    Elizabeth K. C. Schwartz, João Paulo De Aquino, Mehmet Sofuoglu · 2024 · British Journal of Clinical Pharmacology
89. The protective effect of hydromorphone to ischemia in rat glial cells
    Young Sung Kim, Woon Young Kim, Yeon-Hwa Kim, Ji Won Yoo, Too Jae Min · 2016 · SpringerPlus
90. Morphine consumption is associated with systemic inflammation in children undergoing allogeneic hematopoietic stem cell transplantation
    Silvia De Pietri, B Nielsen, Marianne Ifversen, Katrine Kielsen, Klaus Müller · 2019 · Immunopharmacology and Immunotoxicology
91. New pharmacological perspectives and therapeutic options for opioids: Differences matter
    Andrew A Somogyi, Stefan T Musolino, Daniel Thomas Barratt · 2022 · Anaesthesia and Intensive Care
92. Epidemiologic and Molecular Pathophysiology of Chronic Opioid Dependence and the Place of Naltrexone Extended-Release Formulations in its Clinical Management
    Albert Stuart Reece · 2012 · Substance Abuse Research and Treatment
93. Mu opioid receptor regulation of glutamate efflux in the central amygdala in response to predator odor
    Jeffrey Parrilla-Carrero, Kris Ford Kaigler, George H. Hartshorn, Jim R. Fadel, Marlene A. Wilson · 2019 · Neurobiology of Stress
94. Comprehensive Mechanisms and Non-Invasive Treatment for Complex Regional Pain Syndrome: A Narrative Review
    Hoa Ngan Doan, Min Cheol Chang · 2025 · Journal of Pain Research
95. Elevated serum TLR4 level as a potential marker for postsurgical chronic pain in pediatric patients with different approaches to analgesia
    Ya.V. Semkovych, Dmytro Dmytrіiev · 2022 · Frontiers in Medicine
96. Exploration of the Differentially Expressed Long Noncoding RNAs and Genes of Morphine Tolerance via Bioinformatic Analysis
    Yong Qiu, Ling‐bing Meng, Chenyi Di, Yu-hu Huo, Bo-chen Yao, Tengjiao Zhang, Zhen Hua · 2019 · Journal of Computational Biology
97. A review of the genomics of neonatal abstinence syndrome
    Elizabeth Yen, Nathan Gaddis, Lauren L. Jantzie, Jonathan M. Davis · 2023 · Frontiers in Genetics
98. Dissecting the innate immune recognition of morphine and its metabolites by TLR4/MD2: an in silico simulation study
    Xiaozheng Zhang, Ran Li, Haoran Xu, Guicai Wu, Siru Wu, Hongshuang Wang, Yibo Wang, Xiaohui Wang · 2023 · Physical Chemistry Chemical Physics
99. Role of phosphodiesterase inhibitor Ibudilast in morphine-induced hippocampal injury
    Mohsen Zhaleh, Marzieh Panahi, Mehri Ghafouriyan Broujerdnia, Rostam Ghorbani, Kambiz Ahmadi Angali, Ghasem Saki · 2013 · Journal of Injury and Violence Research
100. Suppression of the acute upregulation of phosphorylated-extracellular regulated kinase in ventral tegmental area by a μ-opioid receptor agonist is related to resistance to rewarding effects in a mouse model of bone cancer
     Atsushi Nakamura, Hiroko Ono, Azusa Ando, Mikie Hinata, Kazuki Niidome, Shigeki Omachi, Gaku Sakaguchi, Shunji Shinohara · 2016 · Journal of Pharmacological Sciences